Have you ever heard of a biotech unicorn? Although a mythological creature might be what first springs to mind, a unicorn in the business world actually refers to a privately owned company valued at more than $1 billion. Some world-renowned former unicorns include Airbnb, Facebook, and Google. The reason they are called “unicorns” is because it is traditionally very rare for a company to achieve this valuation.In the biotech world, there are only a select few companies with unicorn status that are working on therapeutics. In this article, we take a closer look at 12 biotech unicorns rated in order of their valuations according to CB Insights.Table of contentsAbogen BiosciencesAbogen Biosciences is a Chinese biotech company and is valued at $3.7 billion. This comes as no surprise after it raised $700 million in series C funding back in August 2021, marking one of the largest private biotech funding rounds ever and obliterating the fundraising record for a Chinese mRNA vaccine developer. It then followed this round with another impressive series C+ round in November of the same year, in which it raised $300 million.Abogen is part of a rare breed of Chinese biotechs, having actually developed all of its key messenger RNA (mRNA) platform technologies itself, across mRNA synthesis, delivery, and manufacturing

Cushman & Wakefield said Tuesday that it arranged three new long-term leases and one lease renewal totaling 62,131 square feet at 3 Second St., a 600,000-square-foot Class A office tower in Jersey City.Hyundai Motor America signed a 12,580-square-foot lease on the fifth floor.In addition, Eikon Therapeutics signed a 36,284-square-foot lease on the fourth floor. Bank of Montreal renewed its 10,365-square-foot lease on the 12th floor. And Arco Design/Build signed a 2,902-square-foot lease on the eighth floor.Cushman & Wakefield’s David DeMatteis, Robert Rudin, Mina Shehata and Dirk Hrobsky represented the landlord, funds managed by Ares Management, in the transactions. William O’Keefe, Raymond Trevisan and Don Yahn, also of Cushman & Wakefield, represented Hyundai.“We are thrilled to welcome new tenants and to expand relationships with existing ones to enhance 3 Second St.’s impressive tenant roster,” DeMatteis said. “These leases are further evidence that the best located, highly amenitized buildings attract tenants. The Ares Management Real Estate Group has provided a hands-on approach to ownership and is constantly reinvesting in this asset with hospitality-focused upgrades, including a new, thoughtfully designed tenant sky lounge that is currently underway.”3 Second St

Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites. ABOUT THIRD PARTY LINKS ON OUR SITE. PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links you will leave the PharmiWeb.com website and will be redirected to another site